CITIGROUP INC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$770,578
-36.7%
60,580
-30.0%
0.00%0.0%
Q2 2023$1,218,244
-58.9%
86,523
-54.9%
0.00%
-50.0%
Q1 2023$2,963,373
+60.8%
191,804
+70.6%
0.00%
+100.0%
Q4 2022$1,842,334
-47.1%
112,406
-40.3%
0.00%
-50.0%
Q3 2022$3,482,000
+60.8%
188,218
+14.4%
0.00%0.0%
Q2 2022$2,165,000
+231.5%
164,559
+133.5%
0.00%
Q1 2022$653,000
-84.1%
70,460
-83.2%
0.00%
-100.0%
Q4 2021$4,101,000
+48.1%
419,717
+414.9%
0.00%0.0%
Q3 2021$2,770,000
-35.1%
81,508
-30.0%
0.00%
-33.3%
Q2 2021$4,266,000
-4.7%
116,523
+16.7%
0.00%0.0%
Q1 2021$4,478,000
+565.4%
99,868
+748.0%
0.00%
Q4 2020$673,000
+109.7%
11,777
+87.5%
0.00%
Q3 2020$321,000
-83.7%
6,281
-81.0%
0.00%
-100.0%
Q2 2020$1,974,000
+49.3%
33,056
+3.0%
0.00%
+100.0%
Q1 2020$1,322,000
-28.9%
32,103
+7.5%
0.00%0.0%
Q4 2019$1,860,000
+133.1%
29,869
+27.1%
0.00%0.0%
Q3 2019$798,000
-2.3%
23,501
-35.1%
0.00%0.0%
Q2 2019$817,000
+115.0%
36,222
+121.2%
0.00%
Q1 2019$380,000
-75.4%
16,373
-77.8%
0.00%
-100.0%
Q4 2018$1,545,000
+61.1%
73,598
+197.4%
0.00%
+100.0%
Q3 2018$959,000
+1940.4%
24,748
+1999.1%
0.00%
Q2 2018$47,000
+104.3%
1,179
+4.5%
0.00%
Q1 2018$23,000
+9.5%
1,128
+21.2%
0.00%
Q4 2017$21,0009310.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders